13F Pro

SEC Form 4 reporting owner

Moshkevich Solomon

Moshkevich Solomon has filed 65 Form 4 transactions reported between December 1, 2025 and September 16, 2026, as PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc..

Name as filed: Moshkevich Solomon

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$21.3M
55 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 16, 2026
transaction date

Roles and reported holdings

  • NTRANatera, Inc.
    Dec 1, 2025 – Sep 16, 2026

    PRESIDENT, CLINICALDIAGNOSTICS

    Held directly109,914 sh as of Sep 16, 2026 · Form 4

    24 months: $21.3M sold

Transaction history

All 65 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 16, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSGiftCode G · direct945—Form 4
Sep 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct15,160$5.0M@ $326.89Form 4
Sep 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct600$193K@ $321.91Form 4
Sep 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,400$449K@ $320.92Form 4
Sep 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,000$320K@ $319.76Form 4
Aug 3, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct128$34K@ $268.70Form 4
Aug 3, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,233$330K@ $267.79Form 4
Aug 3, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct192$51K@ $265.27Form 4
Aug 3, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct947$250K@ $263.94Form 4
Aug 3, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct200$52K@ $261.49Form 4
Aug 3, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct300$78K@ $259.98Form 4
Aug 3, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct410$110K@ $267.99Form 4
Jul 28, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,204$306K@ $254.07Form 4
Jul 27, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,010$263K@ $260.49Form 4
Jul 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct300$82K@ $274.06Form 4
Jul 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct2,600$710K@ $272.99Form 4
Jul 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct100$27K@ $267.19Form 4
Jun 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct572$126K@ $220.67Form 4
Jun 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct213$47K@ $219.34Form 4
Jun 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct413$90K@ $218.84Form 4
Jun 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,802$392K@ $217.52Form 4
May 26, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,652$335K@ $202.84Form 4
May 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct150$31K@ $206.93Form 4
May 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct400$82K@ $205.31Form 4
May 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct865$177K@ $204.47Form 4
May 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct505$103K@ $203.32Form 4
May 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct520$105K@ $201.60Form 4
May 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct560$113K@ $200.95Form 4
May 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct405$83K@ $206.16Form 4
Apr 27, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,185$242K@ $204.39Form 4
Apr 27, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct997$203K@ $203.75Form 4
Apr 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct952$194K@ $203.31Form 4
Apr 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,000$202K@ $202.36Form 4
Apr 1, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,048$211K@ $201.32Form 4
Mar 10, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct915$187K@ $204.13Form 4
Mar 9, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSGrant or awardCode A · direct1,774—Form 4
Mar 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct475$95K@ $200.97Form 4
Mar 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,594$319K@ $200.11Form 4
Mar 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct931$185K@ $198.83Form 4
Mar 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOption exerciseCode M · direct5,125$49K@ $9.59Form 4
Feb 27, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSGrant or awardCode A · direct10,051—Form 4
Feb 3, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,639$378K@ $230.77Form 4
Feb 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct16$4K@ $234.00Form 4
Feb 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct600$140K@ $233.24Form 4
Feb 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct850$197K@ $232.33Form 4
Feb 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct576$133K@ $230.84Form 4
Feb 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct878$202K@ $229.96Form 4
Feb 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct80$18K@ $228.50Form 4
Jan 28, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,200$285K@ $237.66Form 4
Jan 27, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,013$244K@ $240.53Form 4
Jan 21, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct293$69K@ $235.00Form 4
Jan 20, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct23,205$5.4M@ $234.74Form 4
Jan 14, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSGrant or awardCode A · direct44,698—Form 4
Jan 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,659$381K@ $229.43Form 4
Jan 2, 2026NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,292$295K@ $228.33Form 4
Dec 15, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSGiftCode G · direct115—Form 4
Dec 12, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSOption exerciseCode M · direct13,500$129K@ $9.59Form 4
Dec 12, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct4,692$1.1M@ $230.76Form 4
Dec 12, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSOption exerciseCode M · direct8,876$85K@ $9.59Form 4
Dec 12, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSGiftCode G · direct180—Form 4
Dec 10, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSOption exerciseCode M · direct22,376—Form 4
Dec 1, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct474$114K@ $239.53Form 4
Dec 1, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct1,527$364K@ $238.24Form 4
Dec 1, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct250$59K@ $237.77Form 4
Dec 1, 2025NTRAPRESIDENT, CLINICALDIAGNOSTICSOpen-market saleCode S · direct749$178K@ $237.23Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.